Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 3/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 1/20 | 1.00 |
| ▸ | MAOB | P27338 | 5/20 | 0.83 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.81 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.81 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.81 |
| ▸ | HPGD | P15428 | 5/20 | 0.81 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.81 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.81 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.81 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.81 |
| ▸ | USP2 | O75604 | 1/20 | 0.81 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.81 |
| ▸ | RECQL | P46063 | 1/20 | 0.81 |
| ▸ | MAPT | P10636 | 5/20 | 0.74 |
| ▸ | TP53 | P04637 | 5/20 | 0.74 |
| ▸ | MEN1 | O00255 | 3/20 | 0.74 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.74 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.74 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.74 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31238410 | 0.92 | TNKS (0.84) | TNKSCYP19A1MAOBCYP3A4KDM4E | |
| 4,7-Dimethoxyflavone SCHEMBL3470601 | 0.91 | MAOB (1.00) | TNKSCYP19A1MAOBCYP3A4KDM4E | |
| 7,3'-Dimethoxyflavone SCHEMBL718068 | 0.90 | KDM4E (1.00) | TNKSCYP19A1MAOBCYP3A4KDM4E | |
| 6-Methoxyflavone SCHEMBL312059 | 0.90 | ABCB1 (1.00) | TNKSCYP19A1MAOBCYP3A4KDM4E | |
| 6-Methoxyflavone SCHEMBL30799564 | 0.90 | ABCB1 (1.00) | TNKSCYP19A1MAOBCYP3A4KDM4E | |
| 6-Methoxyflavone SCHEMBL28930176 | 0.90 | ABCB1 (1.00) | TNKSCYP19A1MAOBCYP3A4KDM4E | |
| 6-Methoxyflavone SCHEMBL28301080 | 0.88 | ABCB1 (0.97) | TNKSCYP19A1MAOBCYP3A4KDM4E | |
| SCHEMBL31238401 | 0.88 | KDM4E (0.85) | TNKSCYP19A1MAOBCYP3A4KDM4E | |
| 6-Methoxyflavone SCHEMBL27697051 | 0.86 | ABCB1 (0.92) | TNKSCYP19A1MAOBCYP3A4KDM4E | |
| 7-Methoxyflavone SCHEMBL28098795 | 0.86 | TNKS (0.73) | TNKSCYP19A1MAOBCYP3A4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220273610-A1 | ANTIMYCOTIC | Karl-Franzens-Universität Graz (AT) | 2022-09-01 | — | — | US | claimed |
| EP-4003016-A1 | ANTIMYCOTIC | Karl-Franzens-Universität Graz (AT) | 2022-06-01 | — | — | EP | claimed |
| WO-2021013930-A1 | ANTIMYCOTIC | Karl-Franzens-Universität Graz (AT) | 2021-01-28 | — | — | WO | claimed |
| EP-3769622-A1 | ANTIMYCOTIC | Karl-Franzens-Universität Graz (AT) | 2021-01-27 | — | — | EP | claimed |
| CN-106455665-A | Fat or oil extract of black ginger and method for producing same | 三得利控股株式会社 | 2017-02-22 | — | — | CN | claimed |
| US-20160361257-A1 | COMPOSITION FOR INCREASING TESTOSTERONE LEVELS AND ENHANCING LIBIDO | FARBER MICHAEL (US) | 2016-12-15 | — | — | US | claimed |
| US-20160361258-A1 | COMPOSITION FOR ENHANCING LIBIDO IN MAMMALS | SMARTEK INTERNATIONAL, INC. | 2016-12-15 | — | — | US | claimed |
| CN-106083793-A | A kind of preparation method of 7 methoxy flavones | 嘉兴学院 | 2016-11-09 | — | — | CN | claimed |
| CN-102993149-A | Method for microwave-assisted synthesis of B-ring substituted flavone compound | UNIV JIANGNAN | 2013-03-27 | — | — | CN | claimed |
| US-20130030045-A1 | METHOD OF PREVENTING AND TREATING OSTEOPOROSIS | TSAI YU-HUI (TW) | 2013-01-31 | — | — | US | claimed |
| CN-101914082-A | Method for synthesizing 7-methoxyflavone | HANGZHOU FST PHARMACEUTICAL CO LTD | 2010-12-15 | — | — | CN | claimed |
| US-6872771-B1 | Tire with rubber containing flavone | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2005-03-29 | — | — | US | claimed |
| JP-2003504327-A | — | — | 2003-02-04 | — | — | JP | claimed |
| EP-1223928-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | Prendergast, Patrick Thomas (IE) | 2002-07-24 | — | — | EP | claimed |
| EP-1109800-A1 | NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE | LG CHEMICAL LIMITED (KR) | 2001-06-27 | — | — | EP | claimed |
| WO-2001003681-A2 | USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS | PRENDERGAST PATRICK T (IE) | 2001-01-18 | — | — | WO | claimed |
| WO-2000012496-A1 | NOVEL CDK INHIBITORS HAVING FLAVONE STRUCTURE | LG CHEMICAL LTD. (KR) | 2000-03-09 | — | — | WO | claimed |
| US-5399584-A | Preventing gastrointestinal damage caused by nonsteroidal antiinflammatory drugs | THE PROCTER & GAMBLE COMPANY (US) | 1995-03-21 | — | — | US | claimed |
| US-12594249-B2 | Soluble curcumin and its derivatives | THERMOLIFE INTERNATIONAL, LLC (US) | 2026-04-07 | — | — | US | disclosed |
| US-5399584-A | Preventing gastrointestinal damage caused by nonsteroidal antiinflammatory drugs | THE PROCTER & GAMBLE COMPANY (US) | 1995-03-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220273610-A1 | ANTIMYCOTIC | ETF1, API5, ERG28 | TNKS 2894/4885CYP19A1 2106/4885MAOB 1572/4885 |
| US-12594249-B2 | Soluble curcumin and its derivatives | SLC2A8, SLC2A2, SLC2A1 | TNKS 4705/4885CYP19A1 1268/4885MAOB 1325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.